HuGE Literature Finder
Records
1
-
9
| Germline BLM mutations and metastatic prostate cancer. The Prostate 2019 Nov . Ledet Elisa M, Antonarakis Emmanuel S, Isaacs William B, Lotan Tamara L, Pritchard Colin, Sartor A Oliv |
| Deleterious Germline BLM Mutations and the Risk for Early-onset Colorectal Cancer. Scientific reports 2015 5 14060. de Voer Richarda M, Hahn Marc-Manuel, Mensenkamp Arjen R, Hoischen Alexander, Gilissen Christian, Henkes Arjen, Spruijt Liesbeth, van Zelst-Stams Wendy A, Marleen Kets C, Verwiel Eugene T, Nagtegaal Iris D, Schackert Hans K, van Kessel Ad Geurts, Hoogerbrugge Nicoline, Ligtenberg Marjolijn J L, Kuiper Roland |
| Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles. PLoS genetics 2012 Sep 8 (9): 9. Thompson ER, Doyle MA, Ryland GL, Rowley SM, Choong DY, Tothill RW, Thorne H, Barnes DR, Li J, Ellul J, Philip GK, Antill YC, James PA, Trainer AH, Mitchell G, Campbell IG |
| High prevalence and breast cancer predisposing role of the BLM c.1642 C>T (Q548X) mutation in Russia. International journal of cancer. Journal international du cancer 2012 Jun 130 (12): 2867-73. Sokolenko Anna P, Iyevleva Aglaya G, Preobrazhenskaya Elena V, Mitiushkina Nathalia V, Abysheva Svetlana N, Suspitsin Evgeny N, Kuligina Ekatherina Sh, Gorodnova Tatiana V, Pfeifer Werner, Togo Alexandr V, Turkevich Elena A, Ivantsov Alexandr O, Voskresenskiy Dmitry V, Dolmatov Georgy D, Bit-Sava Elena M, Matsko Dmitry E, Semiglazov Vladimir F, Fichtner Iduna, Larionov Alexey A, Kuznetsov Sergey G, Antoniou Antonis C, Imyanitov Evgeny |
| Association between polymorphisms in RMI1, TOP3A, and BLM and risk of cancer, a case-control study. BMC cancer 2009 9 (1): 140. Broberg Karin, Huynh Elizabeth, Schläwicke Engström Karin, Björk Jonas, Albin Maria, Ingvar Christian, Olsson Håkan, Höglund Matti |
| Carrier frequency of autosomal-recessive disorders in the Ashkenazi Jewish population: should the rationale for mutation choice for screening be reevaluated? Prenatal diagnosis 2008 Mar 28 (3): 236-41. Fares Fuad, Badarneh Khader, Abosaleh Mohamed, Harari-Shaham Amalia, Diukman Roni, David Miri |
| Coinheritance of BRCA1 and BRCA2 mutations with Fanconi anemia and Bloom syndrome mutations in Ashkenazi Jewish population: possible role in risk modification for cancer development. American journal of hematology 2005 Mar 78 (3): 203-6. Koren-Michowitz M, Friedman E, Gershoni-Baruch R, Brok-Simoni F, Patael Y, Rechavi G, Amariglio |
| Heterozygosity for the BLM(Ash) mutation and cancer risk. Cancer research 2003 Apr 63 (8): 1769-71. Cleary Sean P, Zhang William, Di Nicola Nando, Aronson Melyssa, Aube Jennifer, Steinman Amanda, Haddad Riad, Redston Mark, Gallinger Steven, Narod Steven A, Gryfe Robe |
| Bloom syndrome and Fanconi's anemia: rate and ethnic origin of mutation carriers in Israel. The Israel Medical Association journal : IMAJ 2002 Feb 4 (2): 95-7. Peleg Leah, Pesso Rachel, Goldman Boleslaw, Dotan Keren, Omer Merav, Friedman Eitan, Berkenstadt Michal, Reznik-Wolf Haike, Barkai G |
- Page last reviewed:Jul 25, 2022
- Page last updated:Jan 27, 2023
- Content source: